BTAI
BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- BioXcel Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 206000, a 22.62% increase year-over-year.
- BioXcel Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 592000, a 73.58% decrease year-over-year.
- BioXcel Therapeutics, Inc. annual revenue for 2025 was 642000, a 71.67% decrease from 2024.
- BioXcel Therapeutics, Inc. annual revenue for 2024 was 2.3 M, a 64.20% increase from 2023.
- BioXcel Therapeutics, Inc. annual revenue for 2023 was 1.4 M, a 268.00% increase from 2022.
- BioXcel Therapeutics, Inc. annual revenue for 2022 was 375000.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioXcel Therapeutics, Inc. Earnings — FAQ
BioXcel Therapeutics, Inc. (BTAI) earnings over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BTAI's earnings history?
The chart and table above show BioXcel Therapeutics, Inc.'s earnings by year and by quarter, including the growth rate.